Metaraminol (+)-bitartrate salt
SIGMA/M4773
Synonym: (−)-m-Hydroxyphenylpropanolamine bitartrate salt
CAS Number: 33402-03-8
Empirical Formula (Hill Notation): C9H13NO2 · C4H6O6
Molecular Weight: 317.29
EC Number: 251-502-3
MDL Number: MFCD00238763
Linear Formula: C9H13NO2 · C4H6O6
Product Type: Chemical
| InChI | 1S/C9H13NO2.C4H6O6/c1-6(1 |
| InChI key | VENXSELNXQXCNT-IJYXXVHRSA |
| originator | Merck & Co., Inc., Kenilworth, NJ, U.S. |
| Quality Level | 200 ![]() |
| SMILES string | O[C@H]([C@@H](O)C(O)=O)C( |
| Application: | Metaraminol (+)-bitartrate salt has been used to study the effects of adrenergic agonists in the mouse model of endometriosis. |
| Biochem/physiol Actions: | α-adrenoceptor agonist. Metaraminol may serve as a false sympathetic transmitter. It is a mixed α - and β-adrenergic agonist. |
| Features and Benefits: | This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S. . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1, 5 g in poly bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 + H311 + H331 |
| Precautionary statements | P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311 |
| Hazard Codes | T |
| Risk Statements | 23/24/25 |
| Safety Statements | 26-28-36/37/39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| UNSPSC | 12352200 |


